Other Receivables - Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) - Alpha Spread
F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 17.97 CNY -2.5% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

Fujian Cosunter Pharmaceutical Co Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fujian Cosunter Pharmaceutical Co Ltd
Other Receivables Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
F
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Other Receivables
ÂĄ50.3m
CAGR 3-Years
89%
CAGR 5-Years
30%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Receivables
ÂĄ111m
CAGR 3-Years
-38%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Receivables
ÂĄ297.6m
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
26%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Receivables
ÂĄ1.3B
CAGR 3-Years
-28%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Receivables
ÂĄ3.1B
CAGR 3-Years
16%
CAGR 5-Years
-11%
CAGR 10-Years
0%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Receivables
ÂĄ74.5m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fujian Cosunter Pharmaceutical Co Ltd's Other Receivables?
Other Receivables
50.3m CNY

Based on the financial report for Mar 31, 2024, Fujian Cosunter Pharmaceutical Co Ltd's Other Receivables amounts to 50.3m CNY.

What is Fujian Cosunter Pharmaceutical Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
30%

Over the last year, the Other Receivables growth was 1 933%. The average annual Other Receivables growth rates for Fujian Cosunter Pharmaceutical Co Ltd have been 89% over the past three years , 30% over the past five years .

Back to Top